Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors

by divibasicbldev | Sep 20, 2022 | Press Releases

Mr. Novak brings over 30 years of board and management experience at innovative life sciences companiesMIAMI BEACH, Fla., Sept. 20, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a...

Pasithea Therapeutics Further Strengthens its Scientific Advisory Board with the Appointment of Dr. Merit Cudkowicz

by divibasicbldev | Sep 15, 2022 | Press Releases

— Dr. Cudkowicz is a pioneer in the study and treatment of people with Amyotrophic Lateral Sclerosis (ALS) and other neurological diseases — MIAMI BEACH, Fla., Sept. 15, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA)...

Pasithea Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

by divibasicbldev | Sep 9, 2022 | Press Releases

MIAMI BEACH, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric...

Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference

by divibasicbldev | Aug 18, 2022 | Press Releases

— Annual “From Laboratory to Clinic” conference, held at Trinity College, Oxford University, explores latest discoveries in immunology and molecular medicine —- PAS002 is a proprietary DNA vaccine construct encoding GlialCAM — MIAMI...

Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis

by divibasicbldev | Aug 11, 2022 | Press Releases

— PAS002 is a proprietary DNA tolerizing vaccine construct encoding GlialCAM —- PAS002 effectively reduces disease severity, delays onset of illness, while also reducing relapse severity —- GlialCAM fragment is present in monkeypox virus, supporting...